{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:45:53Z","timestamp":1774079153430,"version":"3.50.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The number of tuberculosis (TB) cases and global TB incidence rates is decreasing according to the latest World Health Organization Global Tuberculosis Report (1). This is very welcome news. However, the 8.8 million incident cases of TB, 1.1 million deaths from TB among HIV-negative people, the 350,000 deaths from HIV-associated TB, and the millions of children orphaned as a result of parental deaths caused by TB provide a stark reminder of the magnitude of devastation caused by TB each year. Advances in understanding TB epidemiology diagnosis and treatment in 2011, many of which were reported in the Journal, provide hope that the annual decline in TB cases will accelerate.<\/jats:p>","DOI":"10.1164\/rccm.201203-0494up","type":"journal-article","created":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T02:18:15Z","timestamp":1339726695000},"page":"1266-1270","source":"Crossref","is-referenced-by-count":9,"title":["Update in Tuberculosis and Nontuberculous Mycobacterial Disease 2011"],"prefix":"10.1093","volume":"185","author":[{"given":"Payam","family":"Nahid","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and Curry International Tuberculosis Center, University of California, San Francisco at San Francisco General Hospital, San Francisco, California; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dick","family":"Menzies","sequence":"additional","affiliation":[{"name":"Respiratory Epidemiology Unit, Montreal Chest Institute, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,6,15]]},"reference":[{"key":"2026032101085979300_bib1","article-title":"World Health Organization report: global tuberculosis control","author":"World Health Organization","year":"2011"},{"key":"2026032101085979300_bib2","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(10)60483-7","article-title":"Tuberculosis control and elimination 2010\u201350: cure, care, and social development","volume":"375","author":"Lonnroth","year":"2010","journal-title":"Lancet"},{"key":"2026032101085979300_bib3","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1164\/rccm.201008-1269OC","article-title":"High prevalence of pulmonary tuberculosis and inadequate case finding in rural western kenya","volume":"183","author":"van't Hoog","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1164\/rccm.201007-1099OC","article-title":"Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases","volume":"183","author":"Brassard","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/rccm.201008-1246CI","article-title":"Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfection","volume":"183","author":"Anandaiah","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1164\/rccm.201008-1207OC","article-title":"Integrated strategies to optimize sputum smear microscopy: a prospective observational study","volume":"183","author":"Cattamanchi","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib7","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/651686","article-title":"Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis","volume":"50","author":"Khan","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2026032101085979300_bib8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1164\/rccm.200903-0439OC","article-title":"Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial","volume":"181","author":"Swaminathan","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201101-0181OC","article-title":"Priorities for screening and treatment of latent tuberculosis infection in the united states","volume":"184","author":"Linas","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib10","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"2026032101085979300_bib11","doi-asserted-by":"crossref","first-page":"e1000443","DOI":"10.1371\/journal.pmed.1000443","article-title":"A multi-country non-inferiority cluster randomized trial of frontloaded smear microscopy for the diagnosis of pulmonary tuberculosis","volume":"8","author":"Cuevas","year":"2011","journal-title":"PLoS Med"},{"key":"2026032101085979300_bib12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1164\/rccm.201012-1984OC","article-title":"Evaluating tuberculosis case detection via real-time monitoring of tuberculosis diagnostic services","volume":"184","author":"Davis","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363","author":"Boehme","year":"2010","journal-title":"N Engl J Med"},{"key":"2026032101085979300_bib14","doi-asserted-by":"crossref","first-page":"e1001067","DOI":"10.1371\/journal.pmed.1001067","article-title":"Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the xpert mtb\/rif assay: a prospective study","volume":"8","author":"Lawn","year":"2011","journal-title":"PLoS Med"},{"key":"2026032101085979300_bib15","doi-asserted-by":"crossref","first-page":"e1001061","DOI":"10.1371\/journal.pmed.1001061","article-title":"Comparison of xpert mtb\/rif with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study","volume":"8","author":"Scott","year":"2011","journal-title":"PLoS Med"},{"key":"2026032101085979300_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.201101-0056OC","article-title":"Evaluation of the xpert mtb\/rif assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting","volume":"184","author":"Theron","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib17","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1164\/rccm.201103-0536OC","article-title":"A multi-site assessment of the quantitative capabilities of the Xpert(r) MTB\/RIF assay","volume":"184","author":"Blakemore","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib18","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1164\/rccm.201009-1449OC","article-title":"Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay","volume":"183","author":"Shah","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib19","doi-asserted-by":"crossref","first-page":"e1000391","DOI":"10.1371\/journal.pmed.1000391","article-title":"Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies","volume":"8","author":"Getahun","year":"2011","journal-title":"PLoS Med"},{"key":"2026032101085979300_bib20","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1164\/rccm.201004-0620OC","article-title":"Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana","volume":"183","author":"Samandari","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201006-0974OC","article-title":"Negative and positive predictive value of a whole-blood interferon-{gamma} release assay for developing active tuberculosis: an update","volume":"183","author":"Diel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2026032101085979300_bib23","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1164\/rccm.201012-1949OC","article-title":"Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice","volume":"183","author":"Zhang","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib24","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1164\/rccm.201105-0827WS","article-title":"CDC\/NIH workshop. Tuberculosis biomarker and surrogate endpoint research roadmap","volume":"184","author":"Nahid","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1164\/rccm.201011-1924OC","article-title":"Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant mycobacterium tuberculosis through efflux","volume":"184","author":"Louw","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/cid\/cir889","article-title":"Totally drug-resistant tuberculosis in india","volume":"54","author":"Udwadia","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2026032101085979300_bib27","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1164\/rccm.201103-0397OC","article-title":"Short-course chemotherapy with tmc207 and rifapentine in a murine model of latent tuberculosis infection","volume":"184","author":"Zhang","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib28","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1164\/rccm.201106-0995PP","article-title":"Tuberculosis drug development: ensuring people living with HIV are not left behind","volume":"184","author":"Luetkemeyer","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101085979300_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1164\/rccm.201003-0395OC","article-title":"Clinical significance of differentiation of mycobacterium massiliense from mycobacterium abscessus","volume":"183","author":"Koh","year":"2011","journal-title":"Am J Respir Crit Care Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/185\/12\/1266\/67251752\/ajrccm_185_12_1266.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/185\/12\/1266\/67251752\/ajrccm_185_12_1266.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:09:05Z","timestamp":1774069745000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/185\/12\/1266\/8508002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,6,15]]},"published-print":{"date-parts":[[2012,6,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201203-0494up","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,6]]},"published":{"date-parts":[[2012,6]]}}}